AI assistant
bioAffinity Technologies, Inc. — Director's Dealing 2024
Jul 3, 2024
35439_dirs_2024-07-02_80a6fb44-637a-48fa-abbb-8384f1da8d08.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: bioAffinity Technologies, Inc. (BIAF)
CIK: 0001712762
Period of Report: 2024-07-01
Reporting Person: Rubin Gary D (Director, 10% Owner)
Reporting Person: Harvey Sandler Revocable Trust (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-07-01 | Common Stock | A | 33784 | — | Acquired | 146597 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1584144 | Indirect |
Footnotes
F1: Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024.
F2: Represents shares of common stock owned directly by the Harvey Sandler Revocable Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. Rubin, as co-trustee of the Trust. Mr. Rubin disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.